🏥Change in NIH Meeting for HIV/AIDS Study Section
The Department of Health and Human Services announces a change in the details of the HIV/AIDS Intra- and Inter-personal Determinants and Behavioral Interventions Study Section meeting. This includes a new contact person and time modifications for the scheduled event, which remains closed to the public.
Learn More🧬NIH Announces Closed Meeting for Aging Research Grant Review
The Department of Health and Human Services has announced a closed meeting of the National Institute on Aging's Special Emphasis Panel. The meeting will focus on reviewing grant applications in clinical trials for aging conditions, with discussions expected to involve confidential trade secrets and personal information. The meeting is set to be held virtually on April 18, 2025.
Learn More🧪NIH Notice of Closed Meeting for Grant Application Review
The National Institute of Allergy and Infectious Diseases has announced a closed meeting to review and evaluate grant applications. This meeting is part of ongoing federal efforts to advance research in allergy, immunology, and infectious diseases, and will address confidential aspects related to the applications under consideration.
Learn More🏥Notice of NIH Meeting for Grant Applications in Health Sector
The National Institutes of Health announces a closed meeting to review grant applications related to complementary and integrative health. The meeting will evaluate proposals that may involve confidential commercial information, emphasizing the importance of privacy during the grant evaluation process. Participants including a Scientific Review Officer will oversee discussions related to potential funding in this health sector area.
Learn More🏥National Institute on Aging Notice of Closed Meeting and Grant Review
The Department of Health and Human Services announces a closed meeting for the National Institute on Aging's Special Emphasis Panel to evaluate grant applications. The discussion will be confidential, protecting sensitive information and personal privacy related to the funding process. The meeting is scheduled for April 15-16, 2025, and will be conducted virtually.
Learn More💼NIH Closed Meeting on Grant Applications for Allergy and Infectious Diseases
The National Institute of Allergy and Infectious Diseases announces a closed meeting to review and evaluate grant applications. This session highlights critical funding opportunities for stakeholders in the health research community, focusing on novel approaches for radiation biodosimetry and related medical countermeasures, while ensuring confidentiality and privacy in sensitive discussions.
Learn More🧬Upcoming NIH Grant Review Meetings
The Department of Health and Human Services announces a series of closed meetings conducted by the National Institutes of Health. These meetings will review grant applications in various health-related fields, providing insights into funding opportunities for businesses engaged in health research and innovation.
Learn More🧬NIH Closed Meetings for Grant Evaluations
The Department of Health and Human Services announces closed meetings of the Center for Scientific Review to evaluate grant applications addressing cancer biology, bioengineering, and early-stage research initiatives. These meetings will provide insights into funding opportunities for health-related research projects, fostering innovation and collaboration in the biomedical sector.
Learn More🧠NIH Notice
This regulatory notice announces a closed meeting of the National Institute of Mental Health's Special Emphasis Panel to review grant applications. The meeting will be conducted virtually and is closed to the public due to the confidential nature of the discussions, which may involve sensitive trade secrets and personal information. Contact details for further inquiries are provided.
Learn More💰NIH Notice of Meeting
The National Institutes of Health (NIH) is announcing a closed meeting for the National Center for Complementary and Integrative Health to review grant applications. The meeting details, including dates and agenda, highlight the evaluation of innovative clinical trials in remote and mobile health interventions, while ensuring confidentiality regarding sensitive information.
Learn More